Arrowhead Pharmaceuticals (ARWR) Research & Development (2010 - 2026)
Arrowhead Pharmaceuticals' Research & Development came in at $198.22 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 22.1% from $162.37 million a year earlier and up 14.4% from the prior quarter.
Arrowhead Pharmaceuticals (ARWR) Research & Development (2010 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Arrowhead Pharmaceuticals reported Research & Development of $723.37 million, up 27.3% year-over-year; for FY2025 (ended Sep 30, 2025), it was $607.16 million, up 20.0% from FY2024.
- Research & Development has increased in each of the last eight fiscal years, with a five-year compound annual growth rate of 36.3% (FY2020 to FY2025).
- Going back by fiscal year, Research & Development was $505.87 million in FY2024 (+43.2%), $353.19 million in FY2023 (+18.8%), $297.31 million in FY2022 (+44.1%) and $206.34 million in FY2021 (+60.1%).
- The fiscal Q3 2026 figure represents the highest quarterly Research & Development in data going back to fiscal Q3 2010.
- Year-over-year, Research & Development has increased for 13 consecutive quarters, with growth averaging 25.2% over the last eight quarters.
- The fastest year-over-year change in Research & Development over five years came in fiscal Q1 2022 (growth of 79.9%), and the weakest in fiscal Q2 2023 (a decline of 1.5%).
- Business Quant data shows ARWR's Research & Development at $173.25 million (Q2 2026), $177.2 million (Q1 2026) and $174.69 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Arrowhead Pharmaceuticals | 9.24 Bn | 4.02 Bn | - | 198.22 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 198.22 Mn |
| Mar 31, 2026 | 173.25 Mn |
| Dec 31, 2025 | 177.20 Mn |
| Sep 30, 2025 | 174.69 Mn |
| Jun 30, 2025 | 162.37 Mn |
| Mar 31, 2025 | 133.10 Mn |
| Dec 31, 2024 | 137.00 Mn |
| Sep 30, 2024 | 135.83 Mn |
| Jun 30, 2024 | 152.43 Mn |
| Mar 31, 2024 | 101.12 Mn |
| Dec 31, 2023 | 116.49 Mn |
| Sep 30, 2023 | 99.86 Mn |
| Jun 30, 2023 | 94.76 Mn |
| Mar 31, 2023 | 74.88 Mn |
| Dec 31, 2022 | 83.70 Mn |
| Sep 30, 2022 | 83.38 Mn |
| Jun 30, 2022 | 72.18 Mn |
| Mar 31, 2022 | 75.99 Mn |
| Dec 31, 2021 | 65.77 Mn |
| Sep 30, 2021 | 65.77 Mn |
Arrowhead Pharmaceuticals Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=ARWR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "ARWR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=ARWR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();